COVID-19

EMA Committee for Medicinal Products for Human Use Adopts Positive Opinion Recommending Authorization of Moderna’s COVID-19 mRNA Vaccine Targeting the SARS-COV-2 Variant JN.1

Moderna's updated COVID-19 mRNA vaccine will be available for the 2024-2025 vaccination season, pending a European Commission authorization decision CAMBRIDGE,…

1 year ago

Zomedica Secures CE Mark for TRUVIEWTM Digital Microscope & Telepathology System, Expanding Global Market Opportunities

CE Mark approval opens European market for TRUVIEW system ANN ARBOR, MI / ACCESSWIRE / September 5, 2024 / Zomedica…

1 year ago

Palisade Bio Reports Data Demonstrating PDE4B Expression in Patient Cohorts Could be Utilized as a Potential Marker for Patient Stratification

Curated data show expression of PDE4B above a specific measurable threshold observed in 70% of adult colitis patients and 90%…

1 year ago

Fresenius Medical Care Grows Number of U.S. Patients Using Company’s Home Hemodialysis Machines, Launches NxStage® Versi®HD with GuideMe Software

Fresenius Medical Care achieves growth milestone of more than 14,000 U.S.-based patients using the Company's NxStage systems to perform Home…

1 year ago

Better Preparing for Future Pandemics

Over $4 million for cutting-edge infrastructure at INRS LAVAL, QC, Sept. 3, 2024 /CNW/ - As the climate continues to change,…

1 year ago

Leidos awarded CDC’s National Health Safety Network modernization contract

RESTON, Va., Sept. 3, 2024 /PRNewswire/ -- Leidos (NYSE:LDOS), a Fortune® 500 innovation company, was recently awarded the National Healthcare Safety Network (NHSN)…

1 year ago

AngioDynamics Announces CE Mark Approval in Europe for the Auryon System

Regulatory approval enables entry of Auryon Atherectomy System in European marketLATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative…

1 year ago

Seegene and Springer Nature Launch ‘Nature Awards MDx Impact Grants’ to Innovate Syndromic PCR Diagnostic Assays

-  Nature Awards MDx Impact Grants in partnership with Seegene extends commitment to external innovation.-  Global research teams invited to…

1 year ago

Taiwan Food & Drug Administration Approves Moderna’s COVID-19 mRNA Vaccine Targeting the SARS-COV-2 Variant JN.1

CAMBRIDGE, MA / ACCESSWIRE / September 2, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced that the Taiwan Food & Drug…

1 year ago

Junshi Biosciences Announces 2024 Interim Financial Results and Provides Corporate Updates

SHANGHAI, Aug. 30, 2024 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a leading…

1 year ago